Last reviewed · How we verify
NCT04816370
Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions
NA trial testing FSFI in Primary Sjögren Syndrome in 68 participants. Completed in 25 January 2021.
15 November 2020
Quick facts
| Lead sponsor | Ankara Education and Research Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 68 |
| Start date | 2 July 2015 |
| Primary completion | 15 November 2020 |
| Estimated completion | 25 January 2021 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- FSFI
Conditions studied
- Primary Sjögren Syndrome — all drugs for Primary Sjögren Syndrome →
Sponsor
Ankara Education and Research Hospital
Who can join
Adults 20 to 70, female only, with Primary Sjögren Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A total of 68 women with pSS and 135 healthy female patients were included in the study. All women in the study and control groups were evaluated gynecologically, and genital findings during the examination and variables related to pSS were recorded. Women's sexual functions were evaluated with the Female Sexual Function Index (FSFI) and quality of life was evaluated using the Health Status Questionnaire-Short Form 36.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04816370
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of FSFI
Trials testing the same drug.
- NCT05900869 — Reduction Nymphoplasty: Assessment of the Impact on Sexuality, Self-Esteem and Screening for Dysmorphophobia · completed
- NCT03837028 — The Human Papilloma Virus Effect on Sexual Life · completed
Other recruiting trials for Primary Sjögren Syndrome
Currently open trials in the same condition.
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07324733 — Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging · NA · recruiting
- NCT06440525 — A Study of RSLV-132 in Females With Sjögren's Disease · Phase 2 · recruiting
- NCT06528197 — Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine · recruiting
- NCT06361745 — Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases · NA · recruiting
Other Ankara Education and Research Hospital trials
Trials by the same sponsor.
- NCT07287761 — Comparison of Erector Spinae Plane Block and Serratus Posterior Superior Intercostal Plane Block in Postoperative Pain M · recruiting
- NCT05927727 — Benign-Malign Differentiation of Axillary Lymph Nodes: The Role Of Superb Microvascular Imaging · NA · completed
- NCT04698083 — Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19 · completed
- NCT03794219 — Is Kinesio Taping Effective to the Radial Nerve in Patients With Lateral Epicondylitis? · NA · completed
- NCT03737916 — The Effect of Perineural Dextrose Injection in Patients With Ulnar Neuropathy at the Elbow · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04816370 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Education and Research Hospital
- Last refreshed: 25 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04816370.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing